Nanotherapeutics for autoimmunity becomes mainstream

Clin Immunol. 2015 Sep;160(1):1-2. doi: 10.1016/j.clim.2015.07.006. Epub 2015 Jul 11.

Authors

Nick Giannoukakis¹, Wilson S Meng²

Affiliations

¹ Institute of Cellular Therapeutics, Allegheny Health Network, Pittsburgh, PA, USA. Electronic address: ngiannou@wpahs.org.
² Division of Pharmaceutical Sciences, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA, USA. Electronic address: meng@duq.edu.

No abstract available

Publication types

Editorial

MeSH terms

Autoimmune Diseases / therapy*
Autoimmunity
Drug Delivery Systems / methods*
Humans
Nanomedicine / methods*
Nanomedicine / trends*

Grants and funding